What is Oppenheimer's price target for PRTA?

Oppenheimer's latest stated price target for Prothena Corporation plc (PRTA) is $100, from its action on Sep 27, 2021.

What is Oppenheimer's rating on PRTA?

Oppenheimer rates PRTA Perform, a neutral rating, as of May 27, 2025.

When did Oppenheimer last change its view on PRTA?

On May 27, 2025, Oppenheimer downgrades to Perform from Outperform.

Oppenheimer PRTA price target and rating history

Prothena Corporation plc (PRTA) · Health Care

Oppenheimer rates Prothena Corporation plc (PRTA) Perform with a $100 price target, as of its latest action on May 27, 2025. It has published 5 rating actions on PRTA since July 2021, including 0 upgrades and 1 downgrade.

Current rating: Perform
Price target: $100
Median target, all firms: Too few
Actions on PRTA: 5

Oppenheimer price target on PRTA

Oppenheimer price target on PRTA, each point a stated target, July 2021 to September 2021.

Every Oppenheimer rating on PRTA

May 27, 2025
DowngradeOppenheimer downgrades to Perform from Outperform
Sep 27, 2021
ReiterateOppenheimer raises its price target to $100 from $90, keeps Outperform
Sep 14, 2021
ReiterateOppenheimer raises its price target to $90 from $82, keeps Outperform
Aug 9, 2021
ReiterateOppenheimer raises its price target to $82 from $76, keeps Outperform
Jul 13, 2021
ReiterateOppenheimer raises its price target to $76 from $54, keeps Outperform

Questions about Oppenheimer and PRTA

What is Oppenheimer's price target for PRTA?: Oppenheimer's latest stated price target for Prothena Corporation plc (PRTA) is $100, from its action on Sep 27, 2021.
What is Oppenheimer's rating on PRTA?: Oppenheimer rates PRTA Perform, a neutral rating, as of May 27, 2025.
When did Oppenheimer last change its view on PRTA?: On May 27, 2025, Oppenheimer downgrades to Perform from Outperform.

More PRTA rating histories

All Oppenheimer ratings PRTA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.